UKHSA: Risk assessment for Omicron BA.2

The latest risk assessment of the BA.2 strain from the UKHSA.   Overall growth advantage – Red: There is evidence of a growth advantage for BA.2 compared to BA.1 in … Continue reading UKHSA: Risk assessment for Omicron BA.2